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Summary  The  present  study  was  performed  to  characterize  the  epidemiology
of  necrotizing  soft  tissue  infection  caused  by  Streptococcus  pyogenes  (n  =  14)  and
Staphylococcus  aureus  (n  =  14)  isolates  collected  at  the  University  of  Iowa  Hospitals
and  Clinics.  An  additional  9  S.  pyogenes  isolates  were  collected  from  patients  being
treated  for  mild  respiratory  infections  and  served  as  a  comparison  sample  in  the  anal-
ysis.  Patient  data  corresponding  to  the  isolates  (n  =  37)  were  also  collected  in  order
to  identify  risk  factors  or  comorbid  conditions  possibly  correlated  with  necrotizing
fasciitis  (NF).  The  prevalence  of  methicillin-resistant  S.  aureus  among  the  study
isolates  was  35.7%  (5/14),  and  the  prevalence  of  the  Panton—Valentine  leukocidin
(PVL)  gene  was  57%  (8/14).  The  S.  pyogenes  NF  (wound)  isolates  (n  =  14)  belonged  to
10  different  emm  types,  none  of  which  appeared  to  be  associated  with  more  severe
disease  when  compared  to  the  milder  infection  (throat)  samples  (n  =  9).  Comorbid
conditions  such  as  diabetes  and  cardiovascular  disease  were  signiﬁcantly  associated
with  NF.  The  results  indicate  that  there  may  be  a  high  prevalence  of  the  PVL  vir-
ulence  factor  in  NF  infections  and  that  spa  type  t008  may  be  responsible  for  the
increasing  incidence  of  S.  aureus  NF  infections  in  Iowa.
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resistant. S.  aureus  isolates  that  were  resistant  toecrotizing  fasciitis  in  Iowa  
ntroduction
n  the  United  States,  the  incidence  of  necrotiz-
ng infections  is  approximately  0.04  cases  per  1000
ersons-years  [1];  nevertheless,  the  disease  is  often
haracterized  by  its  rapid  progression  and  high  mor-
ality rate,  which  is  estimated  to  range  from  25%
o 35%  [1,2],  though  some  studies  have  reported
 mortality  rate  as  high  as  50%  [3].  Most  necro-
izing infection  cases  are  caused  by  Streptococcus
yogenes; however,  the  incidence  of  necrotizing
asciitis (NF)  with  Staphylococcus  aureus  identiﬁed
s the  primary  pathogen  is  on  the  rise  [4,5].
To date,  little  is  known  about  the  pathogeni-
ity of  necrotizing  infections,  primarily  regarding
olecular characterization  and  virulence  factors,
s well  as  host  factors  that  may  be  correlated
ith severe  necrotizing  infections.  Three  notable
irulence factors  associated  with  S.  pyogenes  infec-
ion include  emm  type,  mutations  in  the  covR/covS
ystem, and  the  presence  of  superantigens.  Previ-
us research  has  indicated  that  certain  emm  types
ay be  responsible  for  necrotizing  S.  pyogenes
nfections, particularly  emm  types  1,  3,  and  12
6—8].
A key  virulence  factor  of  interest  for  S.  aureus
nfections is  the  presence  of  the  Panton—Valentine
eukocidin  (PVL)  gene.  Of  particular  interest,  two
revious  studies  performed  molecular  typing  on
ubsets  of  methicillin-resistant  S.  aureus  (MRSA)
solates  causing  NF  and  reported  the  presence  of
he PVL  gene  in  100%  of  the  samples  (5/5)  [4,9].
Along with  molecular  characterization,  numer-
us studies  have  investigated  the  association
etween certain  host  factors  and  an  increased
isk of  NF.  Studies  examining  patient  medical
istories have  identiﬁed  a  multitude  of  factors,
ncluding prior  trauma,  surgery,  nonsteroidal  anti-
nﬂammatory  drug  use,  burns,  chronic  alcohol
onsumption, immunosuppressive  drug  use,  cancer,
iabetes,  obesity,  and  renal  disease,  among  others,
hat may  be  correlated  with  NF  [10—12].  However,
tudies also  have  reported  the  occurrence  of  necro-
izing  infections  in  patients  with  no  known  risk
actors  or  comorbid  conditions  [4,11].
The previously  described  ﬁndings  demonstrate
he need  for  further  research  regarding  the  etiol-
gy of  NF.  The  goals  of  our  study  were  to  determine
he molecular  characterization  of  NF  caused  by
. pyogenes  and  S.  aureus,  including  emm  type
S. pyogenes), spa  type,  and  the  presence  of  the
VL and  mecA  genes  (S.  aureus),  and  to  identify
hether speciﬁc  host  factors  are  correlated  with
evere  necrotizing  infections  among  patients  at  the
niversity  of  Iowa  Hospitals  and  Clinics. 3635
aterials and methods
tudy  isolates  (n  = 38)  were  collected  and  stored
t the  University  of  Iowa  Hospitals  and  Clinics
athology Department  between  January  2011  and
eptember  2012.  Fourteen  S.  aureus  and  14  S.
yogenes  samples  were  collected  from  cases  of
ecrotizing  infection;  the  remaining  10  S.  pyo-
enes  isolates  were  obtained  from  throat  cultures
ollected from  patients  being  treated  for mild
espiratory infections  and  served  as  a comparison
n the  analysis.  Isolates  were  attained  from  the
athology  Department  in  October  2012  following
RB approval,  and  were  analyzed  at  the  Center
or Emerging  Infectious  Diseases  with  molecular
yping.
Genomic DNA  extraction  was  performed  using
he Wizard  Genomic  DNA  preparation  kit  (Promega,
I). Polymerase  chain  reaction  (PCR)  was  per-
ormed to  detect  mecA  and  PVL  genes  (lukS,  lukF)
resent  in  the  S.  aureus  isolates  [13,14].  The
taphylococcus protein  A  (spa)  gene  was  ampliﬁed
sing SpaF  (5′-GAACAA-CGTAACGGCTTCATCC-3′)
nd 1514R  (5′-CAGCAGTAGTGCCGTTTGCCT-3′),  as
reviously described  [15,16]; emm  typing  was  car-
ied out  for  all  S.  pyogenes  isolates  [17],  and  16s
RNA PCR  was  performed  with  all  isolates  to  conﬁrm
he species  [18]. Upon  completion  of  16s  rRNA  PCR,
 isolate  among  the  S.  pyogenes  throat  samples  was
ound to  belong  to  the  Streptococcus  parasangui-
is species,  and  was  subsequently  excluded  from
urther  analysis,  leaving  9  throat  infection  isolates.
ultilocus  sequence  typing  was  completed  on  all
ut 1  study  isolate  [19].
All S.  aureus  and  23  S.  pyogenes  isolates  were
ested for  antibiotic  susceptibility  by  using  the
ITEK 2 System  (bioMérieux).  We  used  the  AST-
P71  and  AST-ST01  cards  of  the  VITEK  2  System
or the  antibiotic  susceptibility  testing  of  S.  aureus
nd S.  pyogenes, respectively.  S.  aureus  isolates
ere tested  for  susceptibility  to  benzylpeni-
illin, oxacillin,  tetracycline,  erythromycin,  cipro-
oxacin, moxiﬂoxacin,  minocycline,  clindamycin,
rimethoprim—sulfamethoxazole,  quinupristin/
alfopristin, gentamicin,  levoﬂoxacin,  line-
olid, daptomycin,  vancomycin,  rifampicin,
inocycline, tigecycline,  and  nitrofurantoin.  S.
yogenes isolates  were  tested  for  susceptibility
o benzylpenicillin,  ampicillin,  cefotaxime,  cef-
riaxone, tetracycline,  erythromycin,  clindamycin,
rimethoprim—sulfamethoxazole,  levoﬂoxacin,
inezolid, and  vancomycin.  Isolates  showing  inter-
ediate levels  of  susceptibility  were  classiﬁed  as or  more  classes  of antimicrobials  or  that  were
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resistant  to  oxacillin  were  considered  multidrug
resistant [20].
We  retrieved  patient  data  from  the  medical
records of  the  University  of  Iowa  Hospitals  and
Clinics and  linked  patients’  medical  record  num-
bers to  the  bacterial  specimens  for  the  purposes
of investigating  host  factors  that  may  be  associated
with necrotizing  infection.  Patients’  demographics,
clinical data,  comorbid  conditions,  outcome  vari-
ables, and  specimen-speciﬁc  data  were  extracted
and entered  into  the  database.  Analysis  of  patient
data was  conducted  using  SAS  statistical  software
(version 9.3,  SAS  Institute  Inc.,  Cary,  NC).
Results
Molecular  typing  revealed  9  different  spa  types
among the  S.  aureus  study  isolates,  with  the  only
repeat  type  being  t008  (43%;  n  = 6).  The  prevalence
of MRSA  in  the  study  sample  was  35.7%  (5/14).  All  of
the MRSA  isolates  were  spa  type  t008.  Fifty-seven
percent (8/14)  of  the  S.  aureus  isolates  harbored
the PVL  gene,  while  all  MRSA  isolates  harbored  the
PVL genes.  Most  of  the  S.  aureus  isolates  (86%;
12/14) contained  a  functional  agr.
A total  of  7  different  sequence  types  were
detected among  14  necrotizing  infection  S.  aureus
isolates.  Among  S.  aureus  isolates,  ST8  was  the
most common  sequence  type  identiﬁed  (46.1%;
6/13), followed  by  ST188  (15.4%;  2/13).  No  other
sequence  types  (38.5%;  5/13)  were  found  to  be
repeated  (Table  1a).
Among  the  S.  pyogenes  isolates,  there  were
14 different  emm  types  represented:  17.4%  were
emm12  (n  =  4),  13%  were  emm11  (n  =  3),  13%
were emm89  (n  = 3),  and  8.7%  were  emm77  (n  =  2)
(Table  1b).  A  total  of  15  different  sequence  types
l
a
3
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Table  1a  Molecular  characteristics  of  S.  aureus.
Isolate  ID  Source  mecA  PVL  
1  Necrotizing  infection  −  −  
2  Necrotizing  infection  −  −  
3  Necrotizing  infection  −  −  
4  Necrotizing  infection  −  +  
5  Necrotizing  infection  −  −  
6  Necrotizing  infection  −  −  
7  Necrotizing  infection  +  +  
8  Necrotizing  infection  −  −  
9  Necrotizing  infection  +  +  
10  Necrotizing  infection +  +  
11  Necrotizing  infection  +  +  
12  Necrotizing  infection  −  +  
13  Necrotizing  infection  +  +  
14  Necrotizing  infection  −  +  D.  Thapaliya  et  al.
ere  detected  among  the  14  necrotizing  infec-
ion and  9  throat  infection  S.  pyogenes  isolates.
T36 was  the  most  common  sequence  type  iden-
iﬁed (17%;  4/23),  followed  by  ST678  (13%;  3/23),
T101 (13%;  3/23),  and  ST63  (9%;  2/23).  No  other
equence  types  (48%;  11/23)  were  found  to  be
epeated.
Among 14  S.  aureus  isolates,  oxacillin  resis-
ance was  observed  in  35.7%  (5/14).  Four  isolates
28.6%) were  resistant  to  ciproﬂoxacin;  7  (50%)
ere resistant  to  erythromycin;  2  (14.3%)  were
esistant to  clindamycin;  3  (21.4%)  were  resistant
o levoﬂoxacin;  and  all  14  (100%)  were  resistant
o benzylpenicillin.  Eight  isolates  (57%)  were  mul-
idrug resistant  S.  aureus.  Among  23  S.  pyogenes
solates, 7  isolates  (30.4%)  were  resistant  to  eryth-
omycin;  1  (4.3%)  was  resistant  to  ciproﬂoxacin;
 (34.8%)  were  resistant  to  clindamycin;  1  (4.3%)
as resistant  to  ceftriaxone;  7  (30.4%)  were  resis-
ant to  tetracycline;  and  1  (4.3%)  was  resistant  to
efotaxime.
Sixty-nine  percent  (9/13)  and  31%  (4/13)  of
he NF  patients  were  male  and  female,  respec-
ively. Sixty-nine  percent  of  the  patients  (9/13)
ere white,  and  31%  (4/13)  were  African  Ameri-
an. The  median  age  of  the  patients  was  48  years
n =  13;  mean,  42.69;  standard  deviation,  12.65;
ange,  21—61)  (Table  2).
The median  length  of  hospitalization  was  10
ays (n  =  13;  mean,  12.4;  standard  deviation,  10.2;
ange, 1—38  days).  The  majority  of  patients  (92%;
2/13)  diagnosed  with  NF  underwent  surgery.  The
ites of  NF  included  the  extremity  (left  foot:  2;  right
oot: 1;  left  ankle:  1;  left  lower  leg:  1;  right  lower
eg: 2)  in  7 patients  (53.8%),  trunk  (left  upper  back
nd back  trunk)  in  2  patients  (15.4%),  perineum  in
 patients  (23.1%),  and  both  trunk  and  extremity  in
 patient  (7.7%)  (Table  2).
spa  AST  MLST  agr  phenotype
t189  P,  C,  E,  Cl  ST188  Functional
t1109  P,  O,  C,  L,  E  ST97  Functional
t701  P,  E,  Cl  ST6  Functional
t008  P,  E  ST8  Functional
t088  P  ST5  Functional
t8870  P  ST188  Functional
t008  P  ST8  Functional
t5051  P  ST45  Functional
t008  P,  T,  TS  ST8  Functional
t008  P,  O  ST8  Functional
t008  P,  O,  C,  L,  E  ST8  Functional
t094  P  ST15  Dysfunctional
t008  P,  O,  C,  L,  E  ST8  Functional
t10075  P,  O,  E  ST152  Dysfunctional
Necrotizing  fasciitis  in  Iowa  637
Table  1b  Molecular  characteristics  of  S.  pyogenes.
Isolate  ID  Source  EMM  type  AST  MLST
15  Necrotizing  infection  emm1.0 —  ST28
16  Necrotizing  infection  emm6.4 —  ST382
17  Necrotizing  infection emm12.0 — ST36
18  Necrotizing  infection emm87.0 — ST62
19  Necrotizing  infection  emm102.2  C,  CT,  E,  Cl  ST60
20  Necrotizing  infection  emm28.4  —  ST52
21  Necrotizing  infection  emm92.0  E,  Cl,  T  ST82
22  Necrotizing  infection  emm12.0  E,  Cl  ST36
23  Necrotizing  infection  emm103.0  CT,  CX  ST327
24  Necrotizing  infection  emm11.0  E,  Cl,  T  ST678
25  Necrotizing  infection  emm2.0 —  ST55
26  Necrotizing  infection  emm89.0  —  ST101
27  Necrotizing  infection  st106M.5  T  ST53
28  Necrotizing  infection  emm89.0  —  ST101
29  Respiratory  infection  emm3.1 Cl  ST15
30  Respiratory  infection  emm89.0  —  ST101
31  Respiratory  infection emm12.0 —  ST36
32  Respiratory  infection  emm77.0  T  ST63
33  Respiratory  infection emm11.0 E,  Cl,  T  ST678
34  Respiratory  infection emm77.0 T ST63
35  Respiratory  infection emm4.0 —  ST39
36  Respiratory  infection emm12.0 E, Cl  ST36
37  Respiratory  infection emm11.0 E, Cl,  T ST678
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oP, benzylpenicillin; C, ciproﬂoxacin; E, erythromycin; C
prim/sulfamethoxazole; CT, ceftriaxone; CX, cefotaxime; —, s
A  majority  of  the  patients  (84.6%;  11/13)
ad at  least  1  comorbid  condition  or  risk  fac-
or; the  most  common  comorbid  condition  was
besity  (69.2%,  9/13),  followed  by  cardiovascu-
ar disease  (61.5%;  8/13),  diabetes  (61.5%;  8/13),
ulmonary  disease  (30.8%;  4/13),  neurological
isorders (peripheral  neuropathy,  schizophrenia,
nxiety, depression,  panic  attack,  attention-deﬁcit
yperactive disorder)  (23%;  3/13),  cancer  (15.4%;
/13), malnutrition  (7.7%;  1/13),  and  illicit  drug
se (7.7%;  1/13).  Two  patients  (15.4%;  2/13)  had
o serious  comorbid  conditions  or  risk  factors
Table  2).  There  was  a  higher  incidence  of  NF
mong men  (69.2%;  9/13)  compared  to  women
30.7%; 4/13).  Similarly,  white  patients  were  more
ffected  (69.2%;  9/13)  than  African—American
atients  (30.7%;  4/13).  No  other  race  or  ethnic-
ty was  reported.  Sixty-nine  percent  (9/13)  and
1% (4/13)  of  the  patients  had  monomicrobial  and
olymicrobial  infections,  respectively  (Table  2).
iscussionore  than  100  distinct  molecular  types  of  S.  pyo-
enes  have  been  identiﬁed  on  the  basis  of  M
rotein, which  is  encoded  by  the  emm  gene  [21].  It
s hypothesized  that  some  emm  types  may  be  more
s
P
L
clindamycin; O, oxacillin; T, tetracycline; TS, trimetho-
tible to all antibiotics tested.
athogenic  than  others  [22]. In  this  study,  only  2
mm types  (emm1.0  and  emm87.0)  were  found  in
F cases.  All  other  NF  cases  diagnosed  in  this  study
ere caused  by  S.  aureus.
In recent  decades,  the  incidence  of  life-
hreatening invasive  infection  of  community-
ssociated  MRSA  (CA-MRSA)  is  increasing  in  many
arts of  the  world  [4]. MRSA  has  been  identi-
ed as  the  most  commonly  isolated  pathogen  from
atients  with  skin  and  soft  tissue  infections  pre-
enting  in  U.S.  emergency  departments  [23]. In
ur study,  38.5%  (5/13)  of  the  NF  infections  were
aused  by  CA-MRSA.  The  results  of  our  study  are
onsistent  with  a nationwide  surveillance  study  that
ound a  high  prevalence  of  MRSA  (51%;  2093/4131)
n clinically  signiﬁcant  S.  aureus  isolates  [24].  In
heir study,  USA300  was  the  most  common  strain
n = 1269;  61%),  and  two-thirds  of  USA300  isolates
riginated  from  wound  and  skin  infections.  Sixty-
our percent  of  the  MRSA  isolates  harbored  PVL
enes [24]. This  is  in  contrast  to  a  study  of  S.  aureus
symptomatic carriage  conducted  in  the  same  area
f Iowa  as  the  current  study,  in  which  only  5.2%
f isolates  collected  were  positive  for  PVL  [25],
uggesting  that  invasive  infections  are  enriched  for
VL-positive  isolates.  Another  study  conducted  in
os Angeles,  California,  reported  29%  (9/31)  of
ases of  NF  were  caused  by  CA-MRSA  [4].
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Table  2  Characteristics  of  the  patients.
Isolate  ID  Age  Sex  Race  or
ethnicity
Organisms
in  positive
culture
Microbial
status
Diagnosis  Duration  of
hospitalization
(days)
Surgery  Site  of  infection  Comorbid
conditions
1  &  15  49  F  White  SA  p NF  16  Yes  Left  lower  leg  DM,  CVD,  OBS
2  31  M  American
Indian
SA  M  CL  2 No  Lower  abdomen  None
3  61  M  African
American
SA  &  SP  P  NF  38  Yes  Left  foot  CVD,  DM,  PD,
peripheral
neuropathy,  OBS
4  57  M  White  SA  M  NFb 6 Yes Right  foot CVD,  DM,  cancer,
OBS
5  51  M  White  SA  M  NF  1 No  Perineal  CVD,  DM,  PD,  OBS
illicit  drug  use
6  44  M  White  SA  M  OST  5 Yes  Right  foot  CVD,  DM,  PD,
GID,  peripheral
neuropathy
7  51  F  African
American
SA  M  NF  15  Yes  Left  upper  back  CVD,  DM,  PD,
OBS,
Schizophrenia
8  52  White  SA  P  NF  4 Yes  Right  lower  leg  CVD
9  32  M  White  SA  (MRSA)  M  NF  25  Yes  Perineal  OBS
10  21  F  White  SA  M  NF  7 Yes  Left  ankle  None
11  23  F  White  SA  (MRSA)  M  NF  13  Yes  Trunk  &  left
upper  arm
DM
12  35  M  White  SA  M  NF  17  Yes  Right  foot  CVD,  DM,  PD,
cancer,  OBS,
malnutrition,
panic  attack
13  36  M  White  SA  (MRSA)  M  NF  4 Yes  Right  lower  leg  OBS
14  48  M  African
American
SA  (MRSA)a P  NF  10  Yes  Back  trunk  CVD,  DM,  OBS
16  32  M  White  SP  M  CL  1 Yes  Right  forearm  Illicit  drug  use,
depression,
anxiety,  ADHD
17  51  F  White  SP  M  BA  1 Yes  Left  breast  None
N
ecrotizing
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18  39  M  African
American
SP  M  NF  5  Yes  Perineal  None
19  21  F  Hispanic/
multiracial
SP  M  AP  &  I  1  No  Neck  (pharyngi-
tis)/extremities
(impetigo)
None
20  39  M  Non-
Hispanic/
multiracial
SP  M  PRT  5  Yes  Left  hip  None
21  21  M  Unknown  SP  M  CRB  &
AP
1  No  Neck  &  right
lower  leg
None
22  44  M  White  SA  (MRSA)
& SP
P  CL  3  No  Left  ankle  OBS
23  23  M  White  SP  M  CL  1  No  Perirectal None
24  41  M  White  SP  M  SI  1  No  Back/left
shoulder  &  arm
GID
25  44  M  White  SA  &  SP P CL  5  Yes Left  forearm GID,  ADHD
26  56  M  White  SA  &  SP P PVD  1  Yes Left  foot CVD,
malnutrition,
GID,  PTSD,
depression
27  48  F  White  SP  M  LCR  1  No  Right  hand  None
28  38  F  White  SP  M  CL  1  No  Left  elbow  GID
Abbreviations used: SP, Streptococcus pyogenes; SA, Staphylococcus aureus;  MRSA, methicillin-resistant Staphylococcus aureus;  M, mono-microbial; P, poly-microbial; NF, necrotizing
fasciitis; CL, cellulitis; OST, osteomyelitis; BA, breast abscess; AP, acute pharyngitis; FVR, fever/fatigue; SI, skin infection; I, impetigo; LCR, hand laceration; PRT, peritonitis; DM,
diabetes mellitus, CVD, cardiovascular disease; PD, pulmonary disease; GID, gastrointestinal disease; ADHD, attention deﬁcit hyperactivity disorder; PTSD, post-traumatic stress disorder.
a Klebsiella pneumonia was also isolated from wound.
b Secondary to diabetic cellulitis.
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In  contrast  to  the  previous  report  of  high  preva-
lence of  monomicrobial  MRSA  in  wound  cultures
(86%; 12/14),  only  3  cases  of  NF  (23%;  3/13)  in
our study  were  caused  by  monomicrobial  CA-MRSA
[4].  However,  consistent  with  a  previous  study  in
which all  of  the  tested  isolates  (n  = 5)  were  ST  8-  and
PVL-positive  [4],  ST8  (USA300/t008)  was  the  most
common  sequence  type  in  our  study,  and  more  than
half of  our  S.  aureus  isolates  and  all  MRSA  isolates
harbored the  PVL  gene.  Although  CA-MRSA  USA300
has been  well  documented  in  many  outbreaks  of
soft tissue  infections,  the  ﬁndings  of  this  study,
those of  another  study  that  documented  16.7%  of
CA-MRSA NF  cases  were  USA  300  [9],  and  those  of
a study  by  Miller  et  al.  [4]  demonstrate  the  rising
incidence of  NF  caused  by  CA-MRSA  in  the  United
States. The  typical  mortality  rate  of  NF  is  about
33% [4]. However,  similar  to  a  previous  study  [4],
none of  the  NF  patients  in  our  study  died;  this  may
be due  to  differences  in  care,  in  study  population,
or in  the  bacteriology  of  the  NF  infections  in  this
hospital.  This  ﬁnding  also  suggests  the  possibility
that the  strain  of  CA-MRSA  causing  NF  in  our  study
population may  be  less  virulent  than  NF  caused  by
other organisms.
Previous  studies  have  documented  several  risk
factors  for  necrotizing  soft  tissue  infection,  includ-
ing diabetes  mellitus,  intravenous  drug  abuse,
peripheral vascular  disease,  obesity,  malnutri-
tion, blunt  or  penetrating  trauma,  alcohol  abuse,
surgical  incisions,  chicken  pox,  vesicles,  and
immunosuppression  [1,2].  The  majority  of  the
patients  of  this  study  had  at  least  1  comorbid
condition or  risk  factor.  The  S.  pyogenes  study  iso-
lates belonged  to  14  different  emm  types,  with  no
speciﬁc emm  type  being  over-represented  among
the necrotizing  infection  cases  versus  the  mild
respiratory infection  controls;  however,  no  broad
conclusions  can  be  drawn  due  to  the  small  sample
size of  NF  cases  caused  by  S.  pyogenes.
The results  of  this  study  indicate  that  several
spa and  emm  types  are  responsible  for  NF  cases
presenting at  the  University  of  Iowa  Hospitals  and
Clinics.  All  of  the  MRSA  NF  isolates  in  the  study  were
spa type  t008,  suggesting  this  strain  of  S.  aureus
may be  associated  with  increased  disease  severity
in Iowa.  Our  study  has  several  limitations.  Though
this study  was  prospective  in  design  [11], not  all
microbial  cultures  were  banked  for  later  analysis.
As such,  our  study  included  convenience  samples
of both  S. aureus  and  S.  pyogenes  in  1  hospital,
thus limiting  the  generalizability  of  results.  How-
ever, this  study  provides  insights  into  the  molecular
characteristics of  S.  aureus  and  S.  pyogenes  caus-
ing NF  at  University  of  Iowa  Hospitals  and  Clinics.
Future research  should  focus  on  analyzing  samples
[D.  Thapaliya  et  al.
rom  all  NF  cases  within  a  facility,  and  analyzing
olecular characteristics  of  all  causative  agents.
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